Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ACST - Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call Transcript

ACST - Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call Transcript

Acasti Pharma Inc.
Acasti Pharma, Inc. (ACST) Q4 2022 Earnings Conference Call June 21, 2022 1:00 PM ET Company Participants Robert Blum - Investor Relations Jan D'Alvise - President and Chief Executive Officer Brian Ford - Chief Financial Officer Monique Champagne - Vice President, Clinical Affairs Conference Call Participants Leland Gershell - Oppenheimer Presentation Operator Good day, and welcome to the Acasti Pharma Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners. Please go ahead. Robert Blum All right. Thank you very much MJ and welcome to Acasti Pharma’s fiscal year and 2022 conference call. On the call with us this afternoon is, Jan D'Alvise, President and Chief

For further details see:

Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Acasti Pharma Inc.
Stock Symbol: ACST
Market: NASDAQ
Website: acastipharma.com
Menu
ACST ACST Quote ACST Short ACST News ACST Articles ACST Message Board
Get ACST Alerts

News, Short Squeeze, Breakout and More Instantly...